RIVASTIGMINE vs ROMIDEPSIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RIVASTIGMINE vs ROMIDEPSIN: Safety Overview
| Metric | RIVASTIGMINE | ROMIDEPSIN |
|---|---|---|
| Total FAERS Reports | 9,123 | 1,282 |
| Deaths Reported | 2,232 | 343 |
| Death Rate | 24.5% | 26.8% |
| Hospitalizations | 2,716 | 458 |
| Average Patient Age | 80.0 yrs | 64.7 yrs |
| % Female Patients | 59.5% | 46.5% |
| FDA Approval Date | Apr 21, 2000 | Mar 13, 2020 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Fresenius Kabi USA, LLC |
| Route | TRANSDERMAL | N/A |
| Marketing Status | Discontinued | Prescription |